ReviewBreast cancer research and treatment2025

The promise of ctDNA-based, molecularly-driven early switch therapy from PADA-1 to SERENA-6.

Leandro Jonata Carvalho Oliveira et al.PubMed ↗Publisher ↗

No numbers read from the abstract.